MedCap AB (publ) (FRA:61MA)

Market Cap	753.88M -13.9%
Revenue (ttm)	203.83M +18.6%
Net Income	21.73M +21.1%
EPS	1.45 +20.8%
Shares Out	n/a
PE Ratio	34.69
Forward PE	21.58
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	50.00
Previous Close	50.10
Day's Range	50.00 - 50.15
52-Week Range	41.20 - 59.60
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 21, 2026

About MedCap AB

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout. It prefers to invest in Biotechnology; Life sciences; Pharmaceuticals; MedTech including healthcare equipment, software, components, and packaging solutions for life science products; and Assistive Tech including digital and physical solutions in cognition, communication, environmental control, alarms, mobility, accessibility, and orth...

• Industry: Investors, not elsewhere classified
• Founded: 2001
• Employees: 647
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 61MA

Financial Performance

In 2025, MedCap AB's revenue was 2.11 billion, an increase of 16.73% compared to the previous year's 1.81 billion. Earnings were 219.80 million, an increase of 5.98%.

Financial numbers in SEK

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jul 28, 2026

Data Sources Report a data error